Master Protocol Workshop

Featured

Want to learn more about Master Protocol Workshop? You've come to the right site!

Daniel Millar, MBA Senior Director, Strategic Business Transformation
Johnson & Johnson, United States
Abby Bronson, MBA Vice President, Patient Advocacy and External Innovation
Edgewise Therapeutics, United States
Amy Burd, PhD Chief Scientific Officer
Eilean Therapeutics, United States
Michelle Detry, PhD Director, Adaptive Trial Execution & Senior Statistical Scientist
Berry Consultants LLC, United States
Sudheer Doss, PhD Chief Data Officer and Head of Business Development
Pancreatic Cancer Action Network, United States
AnnCatherine M. Downing, PharmD Chief Operating Officer - Lilly Research Laboratories
Eli Lilly and Company, United States
Kimberly Ann Fisher, MA Project Manager for Master Protocol Project
Clinical Trials Transformation Initiative (CTTI), United States
Scott Berry, PhD President and Senior Statistical Scientist
Berry Consultants LLC, United States
Lisa LaVange, PhD Professor Emerita
University of North Carolina at Chapel Hill, United States